Peripheral neck nerve tumor: A 73-case study and literature review.


Journal

European annals of otorhinolaryngology, head and neck diseases
ISSN: 1879-730X
Titre abrégé: Eur Ann Otorhinolaryngol Head Neck Dis
Pays: France
ID NLM: 101531465

Informations de publication

Date de publication:
Nov 2019
Historique:
pubmed: 21 9 2019
medline: 5 6 2020
entrez: 21 9 2019
Statut: ppublish

Résumé

Peripheral neck nerve tumors are rare and mostly benign neoplasms. The exceptional malignant forms are very aggressive, and diagnosis is difficult. The objective of this study was to evaluate diagnostic and therapeutic management and identify possible predictive factors. A retrospective study was conducted of 73 patients treated for peripheral neck nerve tumor between 1995 and 2015. Mean age was 44years. The main presenting symptom was a cervical mass, isolated or associated with signs related to the affected nerve structure. Diagnosis was suspected by slow progression of a firm mass, featuring T1 hyposignal and T2 hypersignal on magnetic resonance imaging. Surgery was performed in 99% of cases, completed by adjuvant chemotherapy in case of malignant neuroblastic tumor. Type 1 neurofibromatosis and sudden increase in mass with or without associated pain suggested malignant transformation. Age below 10years suggested neuroblastic tumor. Neck nerve tumors are very often benign with low degenerative potential. Surgery is the treatment of choice after risk/benefit analysis. However, there is no clearly defined consensus regarding the timing of surgery for these lesions.

Identifiants

pubmed: 31537489
pii: S1879-7296(19)30146-2
doi: 10.1016/j.anorl.2019.09.005
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

455-460

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

K Boumaza (K)

Service d'ORL et de Chirurgie Cervico-Faciale, CHU de Nantes Hôtel-Dieu, 1, place A. Ricordeau, BP 1005, 44093 Nantes Cedex 01, France.

G Michel (G)

Service d'ORL et de Chirurgie Cervico-Faciale, CHU de Nantes Hôtel-Dieu, 1, place A. Ricordeau, BP 1005, 44093 Nantes Cedex 01, France.

C Salaud (C)

Service de Neurotraumatologie/Neurochirugie, Centre Hospitalier Universitaire de Nantes, Hôtel-Dieu, 1, place A. Ricordeau, BP 1005, 44093 Nantes Cedex 01, France.

C Bossard (C)

Service d'Anatomopathologie, Centre Hospitalier Universitaire de Nantes, Hôtel-Dieu, 1, place A. Ricordeau, BP 1005, 44093 Nantes Cedex 01, France.

F Espitalier (F)

Service d'ORL et de Chirurgie Cervico-Faciale, CHU de Nantes Hôtel-Dieu, 1, place A. Ricordeau, BP 1005, 44093 Nantes Cedex 01, France.

O Malard (O)

Service d'ORL et de Chirurgie Cervico-Faciale, CHU de Nantes Hôtel-Dieu, 1, place A. Ricordeau, BP 1005, 44093 Nantes Cedex 01, France. Electronic address: omalard@chu-nantes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH